Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy - Top-Institutions - MDSpire

Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy

  • By

  • Elsie Kajese

  • Malte Hachmann

  • Katharina J. Ermer

  • Manuela Erk

  • Lin Alhasaan

  • Michael Kohlhaas

  • Heike Bömmel

  • Lisa Berberich

  • Christopher Carlein

  • Hanna Eberl

  • Katrin Streckfuß-Bömeke

  • Leticia Prates Roma

  • Süleyman Ergün

  • Christoph Maack

  • Srikanth Karnati

  • Jan Dudek

  • June 30, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital and Kennedy Krieger Institute
    The Johns Hopkins Hospital and Kennedy Krieger Institute

    Baltimore, Maryland

    Key Differentiators

    • Cardiology
    • Genetics
    • Metabolism

  • #2

    Boston Children’s Hospital, Harvard Medical School
    Boston Children’s Hospital, Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Cardiology
    • Genetics

Original Source(s)

Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy

  • by Elsie Kajese, Malte Hachmann, Katharina J. Ermer, Manuela Erk, Lin Alhasaan, Michael Kohlhaas, Heike Bömmel, Lisa Berberich, Christopher Carlein, Hanna Eberl, Katrin Streckfuß-Bömeke, Leticia Prates Roma, Süleyman Ergün, Christoph Maack, Srikanth Karnati, Jan Dudek

  • June 30, 2026

Related Content

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

Reduced recurrence of atrial fibrillation after cryoballoon ablation in patients with preprocedural patent foramen ovale: a retrospective single-center observational cohort study

Robotic-assisted percutaneous coronary intervention: current evidence and future directions